human
respiratori
syncyti
viru
rsv
import
caus
acut
lower
respiratori
tract
diseas
infant
worldwid
first
line
defens
respiratori
infect
innat
immun
respons
includ
product
type
iii
interferon
ifn
play
import
role
upon
infect
rsv
multipl
pattern
recognit
receptor
prr
recogn
rsvderiv
pathogenassoci
molecular
pattern
pamp
mount
innat
immun
respons
retinoicacidinduc
genei
rigi
nucleotidebind
oligomer
domaincontain
protein
identifi
import
innat
receptor
mount
type
ifn
rsv
infect
howev
type
ifn
level
remain
surprisingli
low
rsv
infect
despit
strong
viral
replic
poor
induct
type
ifn
attribut
cooper
activ
uniqu
nonstructur
ns
protein
rsv
ie
viral
protein
shown
suppress
product
signal
type
iii
ifn
counteract
plethora
key
host
innat
signal
protein
moreov
increas
number
ifnstimul
gene
isg
identifi
target
ns
protein
recent
year
highlight
underexplor
protein
famili
identif
ns
target
protein
understand
divers
effector
function
goswami
colleagu
propos
hypothesi
ns
degradasom
nsd
complex
multiprotein
complex
made
least
furthermor
crystal
structur
resolv
recent
remark
identifi
structur
paralogu
rsv
matrix
protein
unfortun
structur
data
publish
far
review
briefli
describ
prr
mount
innat
immun
respons
upon
rsv
infect
provid
overview
variou
effector
function
furthermor
discuss
ubiquitin
effector
function
line
hypothesi
nsd
share
featur
canon
proteasom
introduct
human
respiratori
syncyti
viru
rsv
neg
strand
rna
viru
belong
famili
pneumovirida
rsv
major
caus
acut
lower
respiratori
tract
infect
pediatr
popul
increasingli
recogn
import
caus
sever
respiratori
diseas
elderli
despit
major
clinic
impact
rsv
human
health
worldwid
approv
vaccin
effect
antivir
therapi
avail
although
rsv
infect
evok
humor
cellular
immun
respons
requir
clear
infect
respons
provid
strong
protect
subsequ
infect
rsv
earli
infect
viral
replic
sens
host
innat
immun
system
lead
product
type
iii
interferon
ifn
follow
induct
array
gene
code
antivir
protein
addit
ifn
recruit
activ
innat
leukocyt
includ
antivir
monocyt
natur
killer
nk
cell
stimul
adapt
immun
respons
rsv
evolv
marvel
set
mechan
subvert
canon
antivir
respons
mammalian
host
notabl
virtu
nonstructur
ns
protein
innat
immun
system
import
earli
line
defens
pathogen
system
compris
pattern
recognit
receptor
prr
recogn
pathogenassoci
molecular
pattern
pamp
activ
prr
induc
express
cytokin
eg
type
iii
ifn
mount
antivir
state
autocrin
paracrin
fashion
upon
rsv
infect
airway
epitheli
cell
macrophag
dendrit
cell
dc
main
induc
innat
immun
respons
sever
tolllik
receptor
tlr
identifi
act
prr
rsvderiv
pamp
fig
exampl
implic
induct
cytokin
chemokin
upon
rsv
infect
role
well
known
respond
lipopolysaccharid
prr
rsv
current
debat
although
group
report
impair
innat
immun
respons
mice
ehl
colleagu
could
confirm
role
immun
respons
upon
rsv
infect
addit
might
even
play
role
temper
immun
respons
upon
rsv
infect
moreov
type
ifn
product
macrophag
dc
wildtyp
knockout
mice
similar
follow
rsv
infect
final
alveolar
macrophag
primari
sourc
type
ifn
rsvinfect
mice
tlr
play
crucial
role
respons
contrast
retinoicacidinduc
genei
rigi
like
receptor
rlr
import
induct
type
possibl
type
iii
ifn
upon
recognit
rsv
fig
type
ifn
express
strongli
hamper
absenc
mitochondri
antiviralsign
protein
mav
adaptor
protein
rigi
melanoma
differentiationassoci
protein
earli
gene
express
ablat
studi
reveal
rigi
import
rlr
detect
rsv
support
observ
rsv
mrna
could
coimmunoprecipit
rigi
later
howev
rigi
found
coloc
rsv
genom
rna
n
protein
interestingli
wherea
rigi
partial
local
rsvinduc
inclus
bodi
mav
found
nearli
exclus
inclus
bodi
therebi
dramat
blunt
induct
third
class
prr
nucleotidebind
oligomer
domainlik
receptor
nlr
also
import
recognit
rsv
nucleotidebind
oligomer
domaincontain
protein
activ
intact
genom
singlestrand
rna
ssrna
involv
induct
mice
mavsdepend
way
fig
cytoplasm
dna
sensor
cdss
zdna
bind
protein
cyclic
gmpamp
synthas
cga
well
known
induc
innat
immun
respons
upon
recognit
pathogenderiv
doublestrand
dna
dsdna
even
rna
contribut
cdss
innat
sens
rsv
replic
yet
report
contrast
respiratori
virus
ie
influenza
viru
human
respiroviru
formerli
name
human
parainfluenza
viru
nasal
wash
rsvinfect
infant
hardli
firstli
mark
green
involv
product
cytokin
chemokin
upon
rsv
infect
secondli
rigi
possibl
rlr
mark
red
import
induct
type
ifn
thirdli
mark
dark
blue
also
induc
type
ifn
upon
rsv
infect
current
evid
role
cdss
mark
purpl
signal
erassoci
sting
protein
prr
rsv
infect
activ
rlr
induc
associ
mitochondrialassoci
mav
recruit
adaptor
protein
via
adaptor
kinas
subsequ
activ
phosphoryl
activ
transcript
factor
via
adaptor
kinas
activ
ie
ikk
kinas
complex
jnk
mapk
phosphoryl
activ
multipl
transcript
factor
cjun
respect
activ
tlr
lead
recruit
adaptor
protein
eg
tirap
tram
adaptor
signal
via
transcript
factor
activ
prr
signal
ultim
induc
express
cytokin
chemokin
ifn
prr
confirm
like
rsvderiv
pamp
depict
activ
transcript
factor
cd
cytoplasm
dna
sensor
er
endoplasm
reticulum
ifn
interferon
ikk
inhibitor
nuclear
factor
kappab
kinas
inhibitor
nuclear
factor
kappab
kinas
subunit
epsilon
interferon
regulatori
factor
interferon
regulatori
factor
jnk
cjun
ntermin
kinas
mapk
mitogenactiv
protein
kinas
mav
mitochondri
antiviralsign
protein
melanoma
differentiationassoci
protein
myeloid
differenti
primari
respons
protein
nfkb
nuclear
factorkappa
b
nucleotidebind
oligomer
domaincontain
protein
pamp
pathogenassoci
molecular
pattern
prr
pattern
recognit
receptor
rig
retinoicacidinduc
genei
rlr
rigilik
receptor
rsv
respiratori
syncyti
viru
sting
stimul
interferon
protein
tank
bind
kinas
receptor
domaincontain
adapt
molecul
tirap
toll
receptor
domaincontain
adapt
protein
tlr
tolllik
receptor
tumor
necrosi
factor
receptorassoci
factor
tumor
necrosi
factor
receptorassoci
factor
tram
tolllik
receptor
adaptor
molecul
http
contain
appar
viru
evolv
way
outsmart
canon
mammalian
antivir
respons
two
uniqu
viral
protein
respons
suppress
ifn
induct
signal
human
bovin
rsv
strain
lack
andor
explor
liveattenu
vaccin
candid
virus
strongli
attenu
vivo
rsv
infect
model
cotton
rat
calv
chimpanze
well
human
least
calv
chimpanze
retain
abil
induc
antibodi
respons
posit
proxim
negativestrand
rna
genom
abundantli
transcrib
viral
gene
recent
crystal
structur
determin
reveal
protein
compos
flank
interestingli
structur
similar
ntermin
domain
rsv
despit
complet
absenc
primari
sequenc
homolog
strongli
reduc
induct
type
iii
ifn
upon
rsv
infect
infect
recombin
virus
lack
separ
combin
suggest
protein
function
individu
cooper
suppress
ifn
induct
target
multipl
protein
signal
cascad
start
recognit
pamp
prr
end
induct
ifn
gene
express
sever
transcript
factor
widespread
strategi
virus
dampen
innat
immun
respons
counteract
one
earli
signal
step
rlrmediat
ifn
induct
ie
interact
rigi
mav
likewis
rsv
prevent
interact
rigi
adaptor
mav
rsvinfect
cell
cell
overexpress
shown
interact
mav
fig
bind
mav
could
dosedepend
prevent
interact
rigi
mav
cell
furthermor
ban
colleagu
demonstr
ectop
express
cell
interact
pryspri
domain
ubiquitinifnstimul
gene
ligas
tripartit
motifcontain
protein
domain
respons
interact
rigi
bind
pryspri
domain
suppress
polyubiquitin
rigi
essenti
downstream
interact
mav
fig
protein
respiratori
virus
also
target
pryspri
domain
highlight
evolutionari
import
mammalian
antivir
defens
bind
pryspri
domain
protein
influenza
viru
nucleocapsid
protein
sever
acut
respiratori
syndrom
viru
also
counteract
rigi
ubiquitin
interact
ntermin
domain
rigi
upon
overexpress
cell
rsv
infect
cell
fig
overexpress
disrupt
bind
rigi
mav
howev
yet
confirm
endogen
express
rsv
infect
addit
counteract
interact
rigi
mav
may
also
influenc
rigi
express
although
report
find
seem
conflict
rigi
express
cell
strongli
reduc
presenc
rsv
either
express
separ
context
rsv
infect
boyapal
colleagu
howev
report
rigi
express
cell
reduc
follow
infect
rsv
surpris
rigi
isg
possibl
discrep
caus
differ
multipl
infect
moi
use
group
moi
respect
contrast
rigi
mav
appear
resist
downregul
togeth
result
highlight
interact
rigi
mav
suppress
rigi
express
might
reduc
current
clear
whether
andor
disturb
interact
mav
whether
impact
express
level
type
iii
ifn
respons
inhibit
multipl
level
induct
type
iii
ifn
left
panel
ifninduc
signal
right
panel
form
socal
ns
degradasom
complex
stabil
mitochondria
via
mav
nsd
complex
thought
contain
hp
includ
proteasom
subunit
yet
unidentifi
protein
prevent
interact
rigi
mav
differ
way
bind
pryspri
domain
respons
interact
rigi
prevent
polyubiquitin
rigi
necessari
subsequ
interact
rigi
mav
moreov
directli
interact
rigi
interact
mav
suppress
bind
rigi
mav
whether
interact
mav
also
prevent
interact
mav
current
unclear
reduc
protein
express
wherea
modestli
reduc
induc
subsequ
inhibit
differ
propos
mechan
reduc
protein
express
prevent
interact
cbp
therebi
lower
bind
complex
promot
lesser
extent
enhanc
activ
nuclear
transloc
effector
function
synergist
reduc
product
type
iii
ifn
furthermor
also
suppress
type
iii
ifn
receptormedi
signal
transduct
induc
express
target
mrna
code
one
subunit
type
ifn
receptor
may
induc
express
soc
protein
neg
regul
tyrosin
kinas
import
transmit
signal
type
iii
ifn
receptor
inhibit
activ
reduc
protein
level
reduc
phosphoryl
group
howev
report
express
also
reduc
see
text
counteract
antiinflammatori
activ
gr
although
exact
mechan
debat
one
model
interact
nuclear
transloc
compet
gr
nuclear
transloc
recent
evid
suggest
ns
protein
may
also
counteract
antivir
effector
function
isg
eg
degrad
oasl
protein
wherea
degrad
full
dash
line
indic
robust
moder
inhibitori
stimulatori
effector
function
respect
cbp
creb
bind
protein
gr
glucocorticoid
receptor
hp
host
protein
ifit
interferoninduc
protein
tetratricopeptid
repeat
ifitm
interferoninduc
transmembran
protein
ifn
interferon
ifnar
interferon
alphabeta
receptor
inhibitor
nuclear
factorkappa
b
kinas
subunit
epsilon
interferon
regulatori
factor
isg
ifnstimul
gene
jak
janu
kinas
mitogenactiv
protein
kinas
mav
mitochondri
antiviralsign
protein
ns
nonstructur
oasl
oligoadenyl
synthaselik
protein
rigi
retinoicacidinduc
genei
rlr
rigilik
receptor
rsv
respiratori
syncyti
viru
soc
suppressor
cytokin
signal
stat
signal
transduc
activ
transcript
tank
bind
kinas
tripartit
motifcontain
protein
tyk
tyrosin
kinas
http
associ
rlr
mav
lead
recruit
adaptor
tumor
necrosi
factor
receptorassoci
factor
wherea
activ
downstream
serinethreonin
kinas
inhibitor
nuclear
factorkappa
b
kinas
subunit
epsilon
tank
bind
kinas
activ
downstream
kinas
ikk
cjun
ntermin
kinas
jnk
mitogenactiv
protein
kinas
mapk
fig
effect
current
inconclus
group
report
either
overexpress
express
rsv
infect
cell
reduc
express
level
fig
ren
colleagu
howev
observ
differ
endogen
recombin
express
cell
presenc
absenc
possibl
differ
strain
rsv
long
versu
experiment
time
use
explain
oppos
observ
overexpress
cell
modestli
reduc
slightli
enhanc
express
level
respect
fig
effect
howev
observ
rsv
strain
lack
ling
colleagu
also
observ
overexpress
enhanc
overexpress
cell
fig
knowledg
data
publish
possibl
effect
express
coexpress
cell
reduc
recombin
express
suggest
inhibitori
effect
domin
enhanc
effect
result
suggest
suppress
express
although
evid
need
confirm
hypothesi
ectop
express
slightli
suppress
express
enhanc
express
although
effect
need
confirm
rsv
infect
whether
andor
affect
adaptor
investig
yet
evid
indic
rsv
may
inde
affect
express
differ
model
express
shown
downregul
microrna
mirna
interestingli
eilamfrenkel
colleagu
found
express
upregul
rsvinfect
cell
futur
research
may
elucid
whether
rsv
downregul
express
via
upregul
whether
mediat
andor
activ
phosphoryl
transcript
factor
interferon
regulatori
factor
irf
induc
conform
chang
allow
format
homoand
heterodim
transloc
nucleu
phosphoryl
inhibitor
kappa
b
eg
canon
complex
initi
degrad
subsequ
releas
nuclear
transloc
nuclear
factorkappa
b
irf
transcript
factor
essenti
induct
type
iii
ifn
fig
sever
observ
highlight
impair
activ
effector
function
irf
transcript
factor
initi
work
recombin
rsv
strain
lack
one
ns
protein
cell
highlight
prevent
nuclear
transloc
especi
late
hour
post
infect
rsv
replic
cycl
might
part
explain
abil
directli
reduc
recombin
express
fig
addit
prevent
format
bind
protein
cbp
complex
nucleu
may
also
inhibit
gene
express
downstream
nuclear
transloc
fig
import
note
effector
function
demonstr
upon
overexpress
cell
addit
confirm
rsv
infect
necessari
vero
cell
activ
nuclear
transloc
occur
earli
rsv
infect
clearli
enhanc
extent
fig
addit
canon
phosphoryl
subsequ
degrad
rsvinduc
activ
involv
phosphoryl
via
signal
pathway
although
contribut
induct
type
iii
ifn
also
strongli
induc
express
antiapoptot
gene
context
rsv
infect
induct
antiapoptot
cellular
environ
like
domin
contribut
induct
ifn
primarili
control
activ
taken
togeth
suppress
induct
type
iii
ifn
target
multipl
protein
signal
cascad
lead
type
iii
gene
activ
ie
rigi
mav
although
effector
function
confirm
rsvinfect
cell
other
far
identifi
overexpress
alon
futur
research
need
elucid
biolog
relev
recombin
respons
particularli
reloc
mitochondria
bind
type
iii
ifn
heterodimer
receptor
complex
induc
janu
kinas
jak
signal
transduc
activ
transcript
stat
signal
cascad
induc
antivir
state
express
isg
compar
wildtyp
rsv
rsv
strain
lack
andor
sensit
type
ifn
treatment
thu
rsv
ns
protein
also
effector
function
downstream
induct
ifn
synthesi
suppress
ifninduc
antivir
respons
rsvinfect
cell
induc
express
mirna
target
mrna
code
interferon
alphabeta
receptor
unknown
mechan
fig
result
protein
level
reduc
decreas
respons
type
ifn
rsvinfect
cell
thu
favor
rsv
replic
induct
antivir
state
type
type
iii
ifn
requir
phosphoryl
protein
proxim
type
iii
receptor
two
tyrosin
kinas
tyrosin
kinas
respons
phosphoryl
activ
stat
protein
activ
type
iii
ifn
receptor
fig
evid
may
alter
level
activ
statu
kinas
sever
group
report
phosphoryl
total
protein
level
alter
express
andor
whether
also
account
current
clear
infect
airway
epitheli
cell
line
human
metapneumoviru
respiratori
viru
close
relat
rsv
reduc
protein
level
addit
jak
kinas
activ
regul
neg
feedback
loop
consist
suppressor
cytokin
signal
soc
famili
strongest
inhibitor
jak
kinas
report
andor
may
regul
express
andor
therebi
enhanc
rsv
replic
heterodim
phosphoryl
transcript
factor
import
induct
isg
consequ
numer
viral
protein
counteract
protein
use
differ
strategi
eg
prevent
heterodim
format
nipah
hendra
viru
nucleoprotein
suppress
nuclear
transloc
ebolaviru
degrad
andor
paramyxoviru
v
protein
target
rsv
human
tracheobronchi
epitheli
cell
cell
infect
rsv
slightli
increas
total
protein
level
like
stat
protein
isg
product
phosphoryl
induc
exogen
type
ifn
howev
clearli
reduc
fig
whether
also
reduc
phosphoryl
rsv
infect
report
yet
contrast
phosphoryl
nonphosphoryl
protein
level
clearli
reduc
rsv
infect
whether
reduc
level
current
debat
base
overexpress
experi
infect
rsv
strain
lack
andor
sever
group
report
reduc
level
vitro
fig
other
howev
also
observ
reduc
level
overexpress
fig
lo
colleagu
report
recombin
coexpress
reduc
level
stronger
alon
although
express
alon
affect
level
addit
reduc
total
level
rsv
also
seem
suppress
nuclear
transloc
residu
protein
effect
depend
andor
far
possibl
impact
rsv
ns
protein
express
level
vivo
yet
demonstr
mous
appear
resist
primari
human
airway
epitheli
cell
cultur
experi
nonhuman
primat
may
requir
confirm
reduct
also
occur
vivo
evid
rise
ns
protein
also
suppress
antivir
activ
least
isg
product
cell
express
myxoviru
resist
protein
mxa
cell
pretreat
type
ifn
modestli
limit
rsv
replic
moreov
ectop
express
cell
shown
degrad
certain
isg
product
ie
oligoadenyl
synthetaselik
protein
oasl
interferoninduc
protein
tetratricopeptid
repeat
interferoninduc
transmembran
protein
select
manner
fig
import
remark
howev
effector
function
yet
valid
rsv
infect
state
ribaudo
barik
comprehens
screen
known
isg
like
unravel
addit
substrat
andor
affect
induct
apoptosi
cell
shed
individu
cooper
delay
apoptosi
rsvinfect
cell
stronger
earli
express
infect
activ
antiapoptot
protein
kinas
pdk
rac
serinethreonineprotein
kinas
akt
glycogen
synthas
kinas
gsk
pathway
later
infect
hour
activ
pathway
drop
incid
apoptosi
increas
delay
apoptosi
may
facilit
prolong
rsv
replic
increas
viral
yield
typic
hallmark
sever
diseas
follow
rsv
infect
obstruct
smaller
airway
plug
consist
infiltr
immun
cell
mucu
shed
infect
epitheli
cell
primari
human
airway
epitheli
cell
vivo
hamster
model
shown
experi
set
eleg
recombin
viru
construct
rsv
necessari
suffici
induc
shed
infect
epitheli
cell
interestingli
cell
death
associ
nuclear
chang
indic
apoptosi
infect
epitheli
cell
occur
cell
detach
epitheli
layer
moreov
shed
infect
epitheli
cell
coincid
reduc
viral
titer
togeth
result
suggest
express
earli
infect
delay
apoptosi
induc
chang
cell
morpholog
ultim
result
shed
infect
cell
airway
lumen
shed
detach
infect
epitheli
cell
die
shed
ultim
clearanc
mucociliari
transport
infect
epitheli
cell
reduc
rsv
viral
titer
seem
bulk
viral
spread
preced
cell
shed
possibl
earli
chang
cell
morpholog
ultim
lead
shed
infect
epitheli
cell
may
facilit
rsv
product
spread
play
pivot
role
product
spread
rsv
virion
counteract
antiinflammatori
activ
glucocorticoid
receptor
although
rsvinduc
bronchiol
character
sever
inflammatori
respons
use
antiinflammatori
glucocorticoid
shown
clinic
benefit
sever
diseas
base
experi
differ
transform
primari
cell
cultur
well
mice
sever
group
conclud
rsv
inhibit
antiinflammatori
activ
glucocorticoid
via
glucocorticoid
receptor
gr
exact
mechan
account
inhibit
howev
debat
one
group
demonstr
rsv
block
glucocorticoidmedi
gr
activ
primari
human
small
airway
epitheli
cell
monocyt
cell
line
suggest
effect
restrict
rsvinfect
epitheli
cell
mechanist
analysi
cell
suggest
reduc
bind
gr
grrespons
promot
without
affect
gr
total
protein
level
nuclear
transloc
interestingli
knockdown
mav
cell
lower
dexamethasoneinduc
transform
growth
factor
stimul
clone
domain
famili
member
also
known
glucocorticoidinduc
leucin
zipper
protein
gilz
mrna
express
level
similar
rsv
infect
result
suggest
mav
play
role
glucocorticoidinduc
gr
activ
cell
may
indirectli
suppress
gr
activ
inhibit
mav
see
interfer
rigi
xia
colleagu
use
primari
differenti
human
bronchial
epitheli
cell
grown
airliquid
interfac
demonstr
rsv
suppress
glucocorticoidinduc
gr
activ
mechan
involv
upregul
express
model
propos
viral
infect
sens
induc
subsequ
activ
type
receptor
activin
receptorlik
kinas
activ
subsequ
counteract
glucocorticoid
activ
unknown
mechan
accord
aforement
studi
differ
total
protein
level
nuclear
transloc
observ
upon
rsv
infect
interestingli
block
select
inhibitor
reduc
activ
tranilast
compound
use
manag
wide
varieti
diseas
includ
inflammatori
diseas
could
subvert
rsvmediat
suppress
glucocorticoid
activ
although
xia
colleagu
investig
role
may
contribut
rsvinduc
express
upregul
transcript
factor
kruppellik
factor
discuss
next
paragraph
anoth
studi
conclud
rsv
prevent
gr
nuclear
transloc
find
base
experi
cell
mous
lung
tissu
also
analysi
nasopharyng
aspir
rsvinfect
infant
moreov
express
import
gr
nuclear
entri
reduc
mrna
protein
level
mous
lung
wherea
express
mrna
level
reduc
nasopharyng
aspir
upon
rsv
infect
mechanist
found
directli
interact
thu
compet
gr
bind
capac
rsv
suppress
antiinflammatori
effect
glucocorticoid
line
ineffect
glucocorticoid
treatment
sever
ill
rsv
patient
addit
ns
protein
also
regul
express
mirna
rsvinfect
cell
suppress
express
upregul
transcript
factor
kruppellik
factor
drive
express
remark
inhibit
shown
actual
repress
rsv
replic
cell
appar
discrep
could
explain
differ
time
point
infect
analyz
day
versu
day
post
infect
possibl
suppress
rsvinduc
upregul
within
hour
post
infect
wherea
later
express
may
upregul
enhanc
viral
replic
investig
express
level
beyond
hour
post
infect
impact
level
may
result
better
understand
role
rsv
replic
normal
human
bronchial
epitheli
cell
express
upregul
rsv
infect
type
ifn
mechan
respect
increas
absenc
expect
ns
protein
suppress
type
ifn
respons
moreov
promot
activ
famili
member
activ
rsv
infect
signal
pathway
counteract
interact
rigi
mav
see
interfer
rigi
ns
protein
may
dampen
pathway
lead
reduc
activ
subsequ
express
knowledg
effect
andor
rsvinduc
activ
investig
yet
could
readili
test
compar
total
level
activ
cell
infect
wildtyp
rsv
ns
delet
strain
whether
ns
proteinmedi
suppress
favor
counteract
rsv
replic
current
unclear
interfer
adapt
immun
respons
ns
protein
also
play
role
develop
adapt
immun
respons
rsv
infect
partli
consequ
capac
suppress
type
iii
ifn
level
addit
airway
epitheli
cell
rsv
infect
dc
activ
prr
pamp
munir
colleagu
investig
activ
statu
isol
human
monocytederiv
myeloid
dc
upon
rsv
infect
quantifi
sever
matur
marker
includ
cluster
differenti
cd
infect
wildtyp
nsdefici
rsv
strain
highlight
lesser
extent
suppress
matur
human
dc
use
antibodi
suppress
shown
partial
depend
capac
ns
protein
counteract
product
type
ifn
moreov
vivo
pulmonari
convent
dc
activ
measur
upregul
strongli
hamper
rsvinfect
mice
defici
mav
essenti
signal
protein
rsvinduc
type
ifn
product
taken
togeth
result
highlight
type
ifn
play
role
rsvinduc
dc
matur
pleiotrop
effector
function
counteract
product
type
ifn
like
account
reduc
dc
matur
followup
report
munir
colleagu
investig
consequ
reduc
dc
matur
subsequ
activ
tcell
respons
cocultiv
rsvinfect
human
monocytederiv
dc
autolog
cell
delet
found
promot
prolifer
activ
cell
thelper
cell
cell
popul
counteract
rsv
suppress
activ
cell
remark
none
effect
cell
appear
depend
type
ifn
possibl
play
role
cytokin
suppress
dc
type
ifnindepend
manner
contrast
studi
kotelkin
colleagu
mice
identifi
suppress
tcell
respons
type
ifndepend
manner
remark
although
rsvinduc
activ
dc
mav
mav
myeloid
differenti
primari
respons
protein
mice
strongli
impair
mice
could
still
mount
compar
tcell
respons
wildtyp
mice
may
part
explain
approxim
higher
viral
load
mav
mice
compar
wildtyp
mice
addit
small
residu
popul
pulmonari
dc
still
present
mice
could
migrat
drain
mediastin
lymph
node
activ
naiv
cell
mav
mice
still
function
receptor
domaincontain
adapt
molecul
adaptor
dc
may
matur
activ
rsvderiv
doublestrand
rna
dsrna
liveattenu
rsv
vaccin
target
delet
test
use
infant
wherea
strain
delet
insuffici
attenu
delet
strain
addit
mutat
found
overattenu
highlight
import
right
balanc
attenu
immunogen
current
phase
clinic
trial
delet
strain
clinicaltrialsgov
identifi
one
delet
clinicaltrialsgov
identifi
ongo
primari
endpoint
ongo
phase
trial
liveattenu
rsv
strain
lack
either
measur
safeti
vaccin
viru
infect
induct
rsvneutral
titer
knowledg
cellular
immun
respons
immun
liveattenu
rsv
vaccin
investig
take
account
small
size
remark
mani
host
function
affect
rsv
protein
goswami
colleagu
hypothes
form
larg
kda
degrad
complex
call
ns
degradasom
nsd
cell
complex
could
select
degrad
particular
innat
immun
signal
protein
rigi
also
confirm
substrat
nsd
complex
isol
rsvinfect
cell
respect
would
interest
assess
whether
report
ns
target
protein
also
substrat
propos
nsd
complex
rsvinfect
cell
nsd
complex
appear
metast
activ
enhanc
mitochondria
via
mav
possibl
stabil
nsd
complex
interestingli
mavsdefici
cell
stimul
wildtyp
rsv
almost
equal
attenu
rsv
lack
confirm
import
mav
ns
proteinmedi
suppress
type
ifn
respons
line
result
mainli
local
mitochondria
seem
recruit
toward
mitochondria
furthermor
ns
target
protein
innat
protein
reloc
cytoplasm
mitochondria
upon
express
togeth
result
support
hypothesi
format
mitochondrialassoci
nsd
complex
select
degrad
innat
immun
protein
rsvinfect
cell
although
exact
composit
nsd
complex
still
unresolv
presenc
subunit
core
proteasom
spark
idea
nsd
complex
might
act
similar
way
host
proteasom
line
hypothesi
ns
proteininduc
oasl
degrad
partial
block
proteasom
inhibitor
lactacystin
contrast
ns
proteininduc
degrad
appear
insensit
proteasomelik
activ
nsd
complex
support
identif
potenti
induc
host
protein
ubiquitin
wherea
put
elongin
bccullin
boxtyp
ubiquitin
ligas
contain
elongin
c
bind
consensu
sequenc
interestingli
rsv
strain
mutat
residu
appear
essenti
ubiquitin
activ
degrad
nearli
equal
attenu
delet
strain
result
suggest
may
induc
ubiquitin
host
protein
degrad
nsd
complex
current
known
howev
andor
select
mark
innat
immun
protein
degrad
would
explain
select
degrad
activ
nsd
complex
recent
crystal
structur
determin
reveal
remark
structur
homolog
ntermin
domain
matrix
protein
rsv
one
clear
differ
presenc
call
cterminu
truncat
lack
helix
mutat
residu
import
interact
helix
rest
partial
abrog
suppress
induct
attenu
recombin
rsv
strain
result
confirm
helix
import
least
effector
function
unravel
crystal
structur
composit
nsd
complex
would
greatli
enhanc
understand
remark
divers
effector
function
moreov
andor
may
attract
target
antivir
therapi
intranas
administr
nanoparticl
carri
plasmid
encod
small
interf
rna
sirna
mice
reduc
lung
viral
titer
airway
hyperrespons
pulmonari
inflamm
prophylact
well
therapeut
set
recent
small
compound
highthroughput
screen
reveal
candid
inhibitor
highlight
could
target
small
compound
drug
human
rsv
infect
induc
remark
low
level
compar
respiratori
virus
larg
consequ
uniqu
viral
protein
strongli
suppress
induct
signal
ifn
recent
year
evid
rise
addit
antivir
activ
isg
may
hamper
ns
protein
exert
addit
function
delay
cell
apoptosi
loss
associ
stronger
adapt
immun
respons
reduc
vivo
viral
replic
thought
form
socal
ns
degradasom
complex
may
function
proteasomelik
complex
select
degrad
plethora
innat
immun
protein
insight
composit
nsd
resolut
structur
like
help
explain
remark
divers
effector
function
effector
function
howev
far
identifi
artifici
cell
system
interpret
care
largescal
proteinprotein
interact
screen
preferenti
perform
use
multipl
complementari
proteinprotein
interact
techniqu
context
rsv
infect
gener
comprehens
list
host
protein
interact
andor
new
knowledg
combin
cocryst
structur
analysi
rsv
complex
host
protein
factor
instrument
design
antivir
drug
impact
rsvhost
interfac
therebi
complement
directli
act
antivir
